The collection/transfusion of blood products, including transplantation questions
Levels of 2,3 DPG are high
There is a low P50
Levels of 2,3 DPG are low
ATP is generated
All of the above
75% survival of RBCs in a recipient 12 hours after transfusion
80% survival of RBCs in a recipient 12 hours after transfusion
75% survival of RBCs in a recipient 24 hours after transfusion
80% survival of RBCs in a recipient 24hours after transfusion
4 hours
8 hours
12 hours
24 hours
72 hours
1 hour
16 hours
24 hours
72 hours
ATP
2,3 DPG
Dextrose
Sodium phosphate
Rate of transfusion
ATP
2,3 DPG
Dextrose
Sodium phosphate
300
405
425
450
Excessive hemolysis
High levels of potassium
Inosine which may be toxic
Stroma from old red cells
Cytokines
25 Gy in the middle of the component, 15 Gy at any other point
60Gy throughout the entire component container
25Gy throughout the entire component container
15 Gy initally, 25 midpoint, 60 at endpoint
DMSO
Glycerol
HES
Liquid nitrogen
Mannitol
On the top shelf
On the middle shelf
On the bottom shelf
On the inside of the door
Crystallized H30
Carbon Dioxide, Solid
Contains Cryogenic Material
Solid Nitrogen Pellets
Warning: Cold
9 g/dL
10 g/dL
11 g/dL
10.5 g/dL
12 g/dL
HIV positive
Medication for hypertension
Receiving antibiotics
14 years of age
Hemoglobin 12 g/dL
Abdominal
Cardiac
Liver transplant
Orthopedic
Eye surgery
Coordinate the donation process from start to finish
Identify donors and link them to previous records
Process the right number of donors to maintain optimal inventory levels
All of the above
ACE inhibitors
Aspirin containing medications
Fiber
Heparin
Acetaminophen
5%
10%
15%
20%
25%
1
1 to 1.5
2
Up to 3
Immediately before and after the procedure
Each morning
Hourly
Every 3 days
Weekly
CD4
CD8
CD22
CD34
CD44
Administration of dextran to the donor
Apheresis performed in the late afternoon
Combination of chemotherapy and growth factors
Repetitive apheresis in committed donors
Guillain-Barre syndrome
Multiple sclerosis
Myasthenia gravis
TTP
Anti-HIV positive by EIA, no bands seen on Western Blot
Anti-HIV positive by EIA, p24 and g41 seen on Western Blot
Anti-HIV positive by EIA, p17 seen on Western Blot
Anti-HIV positive by EIA, pg120/160 seen on Western Blot
Proscar
Accutane
Soriatane
Tegison
3 days
2 weeks
6 weeks
8 weeks
Platelets
Red cells
White cells
Unknown
500 per microliter
1500 per microliter
10,000 per microliter
500, 000 per microliter
Allogeneic HLA-mismatched donors are used
An organ failed and must be replaced immediately
Autologous HPCs are used
Grafts from pigs are used for heart valves
HLA-matched
HLA-mismatched
Syngeneic (identical twin)
Bone marrow is used rather than peripheral HPC's
Decreased haptoglobin
Decreased hemoglobin
Decreased serum LDH
Increased reticulocytes
Corticosteroids
IVIG
Plasma exchange
Splenectomy
Aspirin meds
10
40
200
400
Actin
Ankyrin
Band 3
Spectrin
Duffy
Kell
Rh
Kidd
Colton
25%
50%
75%
100%
Is associated with increased survival rate
Is associated with ABO incompatible transplants
Occurs within 2 weeks of transplant and lasts 2 months
Occurs in less than 5% of transplant cases
Albumin levels
Anemia
Antibody specificity
Bilirubin levels
.5 of the median
At the median
1.5 of the median
2.0 of the median
Type I
Type IIa
Type IIb
Type III
Epitope switching
Isotype switching
Immune surveillance
Antibody specificity
Le(a-b-)
Le(a+b-)
Le(a-b+)
Le(a+b+)
X-linked dominant
X-linked recessive
Autosomal recessive
Autosomal codominant
HLA-B7
HLA-B17
HLA-B27
HLA-A28
HLA-A1 and HLA-B8
HLA-A1 and HLA-B27
HLA-A30 and HLA-B27
HLA-A1 and HLA-B45
1%
4%
15%
25%
Anklosing spondylitis
Type 1 insulin-dependent diabetes mellitus
Narcolepsy
Rheumatoid Arthritis
450mL
405 mL
385 mL
325 mL
Temporary deferral
Donor typing (ABO/Rh)
QC for typing antisera
Signed consent forms
FFP
Cryo
Platelets
All of the above
None of the above
Quiz Review Timeline +
Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.
Wait!
Here's an interesting quiz for you.